[Thrombocyte aggregation and fibrinolytic activity during long-term beta-block therapy].
作者信息
Jürgensen H J, Nielsen J D, Gormsen J, Kjøller E
出版信息
Ugeskr Laeger. 1982 Nov 22;144(47):3489-92.
PMID:6132474
Abstract
摘要
相似文献
1
[Thrombocyte aggregation and fibrinolytic activity during long-term beta-block therapy].长期β受体阻滞剂治疗期间的血小板聚集和纤溶活性
Ugeskr Laeger. 1982 Nov 22;144(47):3489-92.
2
The effect of beta-blockade on platelet function and fibrinolytic activity.
J Cardiovasc Pharmacol. 1987;10 Suppl 2:S94-8; discussion S99.
3
Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.长期使用心得舒进行β受体阻滞对冠心病患者血小板功能和纤溶活性的影响。
Eur J Clin Pharmacol. 1981;20(4):245-50. doi: 10.1007/BF00618773.
4
[Effects of medical therapy on long-term survival in ischemic heart disease].[药物治疗对缺血性心脏病长期生存的影响]
Minerva Cardioangiol. 1984 Dec;32(12):887-93.
5
[Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].[硝酸盐和β受体阻滞剂对冠心病患者血小板聚集的影响]
Pol Merkur Lekarski. 2000 Feb;8(44):77-9.
6
[Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
Bilt Hematol Transfuz. 1980;8(1):37-43.
7
[Thrombocytic hemostasis in the complex treatment of patients with ischemic heart disease].[血小板止血在缺血性心脏病患者综合治疗中的作用]
Vrach Delo. 1985 May(5):53-6.
8
[Current problems in the conservative long-term treatment of ischemic heart disease].[缺血性心脏病保守长期治疗中的当前问题]
Z Arztl Fortbild (Jena). 1976 Jan 1;70(1):2-13.
9
[The value of drug therapy in coronary disease].[药物治疗在冠心病中的价值]
ZFA (Stuttgart). 1979 Oct 10;55(28):1577.
10
Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.双联抗血小板治疗患者凝血酶生成、纤溶活性及内皮功能障碍的决定因素：维勒三联征中除血小板聚集性以外的因素的作用
Eur Heart J. 2008 Jul;29(14):1729-38. doi: 10.1093/eurheartj/ehn027. Epub 2008 Feb 12.
Zotero 插件